Kura Oncology Inc (NASDAQ:KURA)
| 9.46 Delayed Data As of 4:00pm ET |  +0.20 / +2.16%Today’s Change | 7.41 Today|||52-Week Range 16.14 | -23.77% Year-to-Date |
Latest KURA News | Press Releases
No recent news for Kura Oncology Inc.
Today’s Trading
| Previous close | 9.26 |
| Today’s open | 9.31 |
| Day’s range | 9.09 - 9.46 |
| Volume | 9,562 |
| Average volume (3 months) | 670,225 |
| Market cap | $711.5M |
Data as of 4:00pm ET, 11/28/2023
Growth & Valuation
| Earnings growth (last year) | -3.13% |
| Earnings growth (this year) | -11.78% |
| Earnings growth (next 5 years) | -79.74% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.56 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARCTArcturus Therapeutic... | -0.27 | -1.05% |
| ---- | ||
| SVASinovac Biotech Ltd | 0.00 | 0.00% |
| ---- |
Data as of 3:59pm ET, 11/28/2023
Financials
| Next reporting date | February 22, 2024 |
| EPS forecast (this quarter) | -$0.61 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$135.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
